Professor Justin Stebbing MD MA FRCP FRCPath PhD

Consultant Medical Oncologist, and Professor of Cancer Medicine and Oncology, Imperial College Healthcare NHS Trust.

Professor Justin Stebbing trained in medicine at Trinity College Oxford, where he gained a triple first class degree. After completion of junior doctor posts in Oxford, he undertook a residency at The Johns Hopkins Hospital in the US, returning to London to continue his training in oncology at The Royal Marsden and St Bartholomew's Hospitals. Professor Stebbing’s PhD research investigated the interplay between the immune system and cancer.

Professor Stebbing has published over 400 peer-reviewed papers in journals such as the Lancet, New England Journal, Blood, the Journal of Clinical Oncology, Annals of Internal Medicine, as well as writing for national newspapers and presenting new data on optimal cancer therapies at major international conferences. His focus at LOC is on new therapies in cancer, and the systemic management of patients with a variety of solid malignancies.

He is a member of the Royal College of Physicians, the American Board of Internal Medicine and the Royal College of Pathologists, and sits on the advisory Boards of five biotechnology companies. He chairs the World Vaccine Congress and is on the editorial board of a number of world leading general medical and cancer journals such as the Journal of Clinical Oncology and Oncogene. In 2011 Justin's team discovered a new cancer gene, work that has been published in Nature Medicine. In 2012, the National Institute for Health Research awarded Justin Stebbing its first research translational professorship in cancer medicine, aiming to turn developments in the laboratory into better and more tailored personalised treatments for patients.